Scott Black's ABBV Position Overview
Scott Black (via Delphi Management INC /Ma/) currently holds 6.9K shares of AbbVie Inc. (ABBV) worth $1.6 M, representing 1.49% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Scott Black has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 32.4K shares. Largest reduction occurred in Q4 2015, reducing 114.1K shares.
Analysis based on 13F filings available since 2013 Q2
Scott Black's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Scott Black
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +119,485 | New Buy | 119,485 | $58.54 |
| Q2 2015 | +32,425 | Add 27.14% | 151,910 | $67.19 |
| Q3 2015 | +2,945 | Add 1.94% | 154,855 | $54.41 |
| Q4 2015 | -114,057 | Reduce 73.65% | 40,798 | $59.24 |
| Q1 2016 | +1,161 | Add 2.85% | 41,959 | $57.13 |
| Q2 2016 | -1,821 | Reduce 4.34% | 40,138 | $61.91 |
| Q3 2016 | -3,390 | Reduce 8.45% | 36,748 | $63.08 |
| Q4 2016 | +1,068 | Add 2.91% | 37,816 | $62.62 |
| Q1 2017 | +3,051 | Add 8.07% | 40,867 | $65.16 |
| Q2 2017 | -7,814 | Reduce 19.12% | 33,053 | $72.52 |
| Q3 2017 | -104 | Reduce 0.31% | 32,949 | $88.86 |
| Q4 2017 | -5,204 | Reduce 15.79% | 27,745 | $96.70 |
| Q1 2018 | -5,498 | Reduce 19.82% | 22,247 | $94.66 |
| Q2 2018 | -3,726 | Reduce 16.75% | 18,521 | $92.22 |
| Q3 2018 | -592 | Reduce 3.20% | 17,929 | $94.60 |
| Q4 2018 | +476 | Add 2.65% | 18,405 | $92.20 |
| Q1 2019 | -4,524 | Reduce 24.58% | 13,881 | $80.61 |
| Q2 2019 | -20 | Reduce 0.14% | 13,861 | $72.72 |
| Q3 2019 | -408 | Reduce 2.94% | 13,453 | $75.75 |
| Q1 2021 | +11,297 | Add 0.00% | 11,296 | $108.18 |
| Q2 2021 | +236 | Add 2.09% | 11,532 | $112.64 |
| Q3 2021 | +126 | Add 1.09% | 11,658 | $107.91 |
| Q4 2021 | +396 | Add 3.40% | 12,054 | $135.39 |
| Q4 2022 | +8,160 | Add 0.00% | 8,159 | $161.66 |
| Q2 2023 | +7,926 | Add 0.00% | 7,925 | $134.76 |
| Q3 2023 | +16 | Add 0.20% | 7,941 | $149.10 |
| Q4 2023 | +1,316 | Add 16.57% | 9,257 | $121.42 |
| Q1 2024 | -1,351 | Reduce 14.59% | 7,906 | $182.14 |
| Q2 2024 | +12 | Add 0.15% | 7,918 | $171.51 |
| Q3 2024 | -1,225 | Reduce 15.47% | 6,693 | $197.52 |
| Q4 2024 | -73 | Reduce 1.09% | 6,620 | $177.64 |
| Q1 2025 | -615 | Reduce 9.29% | 6,005 | $209.49 |
| Q2 2025 | -398 | Reduce 6.63% | 5,607 | $185.66 |
| Q3 2025 | +1,323 | Add 23.60% | 6,930 | $231.60 |
Scott Black's AbbVie Investment FAQs
Scott Black first purchased AbbVie Inc. (ABBV) in Q1 2015, acquiring 119,485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Scott Black has held AbbVie Inc. (ABBV) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Scott Black's largest addition to AbbVie Inc. (ABBV) was in Q1 2015, adding 119,485 shares worth $7 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Scott Black's firm, Delphi Management INC /Ma/, owns 6,930 shares of AbbVie Inc. (ABBV), valued at approximately $1.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 1.49% of Scott Black's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Scott Black's peak holding in AbbVie Inc. (ABBV) was 154,855 shares, as reported at the end of Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.